Microbot Medical more than doubles Q2 revenue year-over-year

Microbot Medical reported over 100% revenue growth in the second quarter compared with the same period last year, according to the company's financial update.

• The robotic endovascular company (LIBERTY system) announced the growth; absolute revenue figures were not disclosed in the snippet.
• The update is a corporate financial report and does not introduce new clinical data or device clearance.

RadPigeon summaries are original and for information only. They are not clinical advice.